Finance

Beta
Lists
002399:SHE
Shenzhen Hepalink Pharma Group Co Ltd
CNÂĄ9.35
-2.91%
(-0.28) 1D
Jun 8, 1:50:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002399...
Open
CNÂĄ9.60
High
CNÂĄ9.74
Low
CNÂĄ9.31
Mkt. cap
12.79B
Avg. vol.
4.40M
Volume
3.29M
P/E ratio
36.06
52-wk high
CNÂĄ14.34
52-wk low
CNÂĄ9.31
EPS
CNÂĄ0.26
Shares outstanding
1.25B
No. of employees
2K
Open
CNÂĄ9.60
High
CNÂĄ9.74
Low
CNÂĄ9.31
Mkt. cap
12.79B
Avg. vol.
4.40M
Volume
3.29M
P/E ratio
36.06
52-wk high
CNÂĄ14.34
52-wk low
CNÂĄ9.31
EPS
CNÂĄ0.26
Shares outstanding
1.25B
No. of employees
2K
News stories
From sources across the web
About Shenzhen Hepalink Pharma Group Co Ltd
CEO-
Employees2.15K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Websitehepalink.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.42B
1.38B
1.28B
1.33B
Cost of goods sold
974.82M
884.21M
900.40M
876.31M
Cost of revenue
974.82M
884.21M
900.40M
876.31M
Research and development expenses
62.72M
73.11M
50.33M
36.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.36M
216.50M
252.73M
209.31M
Operating expense
274.56M
291.36M
336.08M
263.62M
Total operating expenses
1.25B
1.18B
1.24B
1.14B
Operating income
173.71M
201.54M
48.03M
190.92M
Other non operating income
-68.37M
182.67M
-254.18M
-122.99M
EBT including unusual items
305.40M
157.96M
-239.36M
207.68M
EBT excluding unusual items
293.42M
188.04M
-97.72M
93.38M
Income tax expense
40.39M
26.52M
-29.37M
20.31M
Effective tax rate
13.23%
16.79%
12.27%
9.78%
Other operating expenses
17.86M
6.60M
16.33M
8.11M
Net income
265.26M
131.73M
-204.09M
187.57M
Net profit margin
18.64%
9.57%
-15.89%
14.09%
Earnings per share
-
-
-
-
Interest and investment income
-
33.52M
-
38.50M
Interest expense
-26.47M
-15.15M
-32.17M
-13.05M
Net interest expenses
-26.47M
18.37M
-32.17M
25.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
251.05M
271.82M
128.19M
271.08M
Gain or loss from assets sale
-1.29M
1.29M
-1.84M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer